Proceedings of the National Academy of Sciences · 1985 · 47 citations · 22 references
Life SciencesCancer BiologyCell BiologyCell ProliferationCell SignalingSignal TransductionCancer-associated FibroblastsGrowth Factor SignalingMelanocytic TumorsActivitiesColony DynamicsConcentrationMitogenic Signal TransductionTransforming Growth Factor Beta RegulationTransforming Growth Factor Beta Signaling ModulationTransforming Growth Factor-beta Signaling
Cells derived from a human melanoma strain by low-serum selection in monolayer were found to be capable of growth in semisolid medium, forming colonies ranging from tight to loose or dispersed. These phenotypes were found to be stable after cloning and retesting. Examination of the biological activities of ectopic peptides produced by a clone that gives rise to loose dispersed colonies revealed the presence of a transforming growth factor beta (TGF-beta; apparent Mr 14,700) and a single TGF-alpha species produced at an unusually high concentration (2.2 ng/ml). Coeluted with the TGF-alpha at approximately 22,500 was a mitogenic activity and a previously undescribed activity capable of modulating the phenotype of induced normal rat kidney fibroblast (NRK-49F) colonies in semisolid medium. This activity can modulate the usual tight colony to express a loose or dispersed phenotype characteristic of the producer cells. Both the possible role these ectopic peptides play in the expression of the transformed phenotype by the tumor cells producing them and the possible correlation between the Mr 22,500 epidermal growth factor-like peptide released by this particular tumor line and high molecular weight epidermal growth factor-like peptides found in the urine of cancer patients are discussed.
22
Richard K. Assoian, Akira Komoriya, Chester A. Meyers et al. · Journal of Biological Chemistry · 1983 · 1.6K citations · Full text
Hans Marquardt, Michael W. Hunkapiller, Leroy Hood et al. · Proceedings of the National Academy of Sciences · 1983 · 404 citations · Full text
Medicine, Cancer Biology, Oncology +10